Jeffrey Gould Moore
Vorstandsvorsitzender bei Curileum Discovery Ltd
Aktive Positionen von Jeffrey Gould Moore
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Curileum Discovery Ltd
 Curileum Discovery Ltd Miscellaneous Commercial ServicesCommercial Services Curileum Discovery Ltd engages in research and development of novel therapeutic targets & drugs. The company was founded by Jeffrey Gould Moore on October 03, 2013 and is headquartered in Harrow, the United Kingdom. | Direktor/Vorstandsmitglied | 03.10.2013 | - |
| Vorstandsvorsitzender | 03.10.2013 | - |
Karriereverlauf von Jeffrey Gould Moore
Ehemalige bekannte Positionen von Jeffrey Gould Moore
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENEDRIVE PLC | Direktor/Vorstandsmitglied | 01.09.2005 | 10.10.2013 |
| Corporate Officer/Principal | 18.10.2009 | 10.10.2013 | |
Phylogix, Inc.
 Phylogix, Inc. Pharmaceuticals: MajorHealth Technology Phylogix, Inc. develops therapeutic drugs. It conducts research on tissue protection and oncology. The firm develops drug candidates in preclinical development, called FRIL to protect cancer patients from the toxic side-effects of chemotherapy. The company was founded in 1998 and is headquartered in Waltham, MA | Gründer | 01.01.1998 | 02.09.2009 |
| Präsident | 01.01.1998 | 02.09.2009 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.1992 | - |
Ausbildung von Jeffrey Gould Moore
| George Washington University | Doctorate Degree |
| The Colorado College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 3 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENEDRIVE PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Phylogix, Inc.
Phylogix, Inc. Pharmaceuticals: MajorHealth Technology Phylogix, Inc. develops therapeutic drugs. It conducts research on tissue protection and oncology. The firm develops drug candidates in preclinical development, called FRIL to protect cancer patients from the toxic side-effects of chemotherapy. The company was founded in 1998 and is headquartered in Waltham, MA | Health Technology |
Curileum Discovery Ltd
Curileum Discovery Ltd Miscellaneous Commercial ServicesCommercial Services Curileum Discovery Ltd engages in research and development of novel therapeutic targets & drugs. The company was founded by Jeffrey Gould Moore on October 03, 2013 and is headquartered in Harrow, the United Kingdom. | Commercial Services |
- Börse
- Insiders
- Jeffrey Gould Moore
- Erfahrung
